Release Date: 28/10/15 10:25 Summary: Half Yearly Report and Accounts 2013 Price Sensitive: No Download Document 750.75KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%